Guidelines by Topic

Polycyclic Hydrocarbons, Aromatic (149)
Search within:  

Sort results by:      



1-20 of 149   Next >
 
1.  
3.  
Naloxegol for treating opioid-induced constipation. 2015 Jul. NGC:010766
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Castration-resistant prostate cancer: AUA guideline. 2013 Apr (revised 2015 Apr). NGC:010730
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
5.  
Depression in children and young people: identification and management in primary, community and secondary care. 2005 (revised 2015 Mar). NGC:010689
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Bladder cancer: diagnosis and management. 2015 Feb 25. NGC:010690
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Intrapartum care: care of healthy women and their babies during childbirth. 2007 Sep (revised 2014 Dec). NGC:010625
National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease. 1999 Aug (revised 2014 Dec). NGC:010629
Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
10.  
Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. 2014 Oct 20. NGC:010623
American Society of Clinical Oncology - Medical Specialty Society; Cancer Care Ontario - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Multiple sclerosis: management of multiple sclerosis in primary and secondary care. 2004 (revised 2014 Oct). NGC:010569
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. 2012 Jul (revised 2014 Oct). NGC:010590
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
13.  
Optimal systemic therapy for early female breast cancer. 2014 Sep 30. NGC:010700
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. 2011 Jan (revised 2014 Sep). NGC:010564
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
15.  
16.  
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. 2012 Feb (revised 2014 Apr). NGC:010329
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
18.  
ACR Appropriateness Criteria® diffuse large B-cell lymphoma. 2014. NGC:010684
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Community management of opioid overdose. 2014. NGC:010618
World Health Organization - International Agency. View all guidelines by the developer(s)
20.  
Testicular germ cell tumours. 2012 Feb (revised 2013 Sep). NGC:010270
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 149   Next >